Global Fund to fight AIDS, TB and Malaria
Full Project Title: Towards Ending AIDS as a Public Health Threat by 2030
Brief Description:
Zimbabwe’s HIV prevalence is at 11.9%, with 1,301,402 million people living with HIV (2021 HIV Estimates). The HIV epidemic in Zimbabwe is characterized by long-term decline, with adult prevalence having fallen from its peak of 26.5% in 1997 to 11.9% in 2021. (2021 HIV Estimates).
The Global Fund HIV grant (2021 - 2023) is designed Towards Ending AIDS as a Public Health Threat by 2030. The project is aligned with Zimbabwe's National Health Strategy (2021 - 2025) and the Zimbabwe HIV and AIDS Strategic Plan, ZNASP III (2021 - 2025). The project also aligns with the National Development Strategy 1, NDS 1 (2021 - 2025). In Zimbabwe, HIV prevalence by sex is most pronounced among young adults (those aged 20-24 years), in which HIV prevalence is three times higher among young women (8.1%) than young men (2.7%). Working with the Ministry of Health and Child Care, National AIDS Council, and Civil Society Organizations, UNDP supports life-saving HIV services in communities across Zimbabwe, including for key populations and vulnerable adolescent girls and young women.
THE UNDP - GLOBAL FUND PARTNERSHIP
The Global Fund to Fight AIDS, Tuberculosis, and Malaria (Global Fund) and UNDP are among the key partners in the national response. UNDP has been the Principal Recipient of the HIV grant in Zimbabwe since 2009.
NEW FUNDING MECHANISM (NFM) 3
Since 2009, the Global Fund has contributed over US$1.61 billion to the fight against HIV in the country (and US$1.9 billion for all grants). UNDP is supporting the delivery of the Global Fund’s NFM 3 (2021 - 2023) of more than US$481 million in Zimbabwe